Log In
Monday 18th June 2018

Red tape for medicines cut

9th August 2006

09082006_medicine_label1.jpgHealth minister Lord Warner has announced plans to reduce the administration involved in regulating over-the-counter medicines; the changes are designed to reduce the burden on industry and allow regulators to focus on medicine safety.

The rules which govern minor changes to labelling and patient information are to be amended to ensure manufacturers do not face disproportionate costs which are passed on to consumers.

The Better Regulation of Over the Counter Medicines Initiative (BROMI) measures have already been put in place, allowing simple changes to medicine labelling and patient information leaflets without going through an expensive and time-consuming formal assessment processes.

President of the Proprietary Association of Great Britain (PAGB), John Harold, welcomed the new programme, saying "OTC ingredients are well established with well known safety profiles. These measures will enable better planning and earlier availability of medicines for consumers when they need them. The new initiatives will cut costs, improve patient information and public health by freeing regulators to focus their time on the newer more complex medicines where the risks associated with their use are less well known."

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018